Full Report
In April 2022, Russian pharmaceutical company Gemotest suffered a data breach that exposed 31 million patients. The data contained 6.3 million unique email addresses along with names, physical addresses, dates of birth, passport and insurance numbers. Gemotest was later fined for the breach.
Analysis Summary
# Incident Report: Gemotest Patient Data Breach (April 2022)
## Executive Summary
In April 2022, the Russian pharmaceutical company Gemotest experienced a significant data breach exposing the personal information of 31 million patients. The compromise resulted in the exfiltration of highly sensitive PII, including passport and insurance numbers. As a consequence of the breach, Gemotest was subsequently fined by regulatory bodies.
## Incident Details
- Discovery Date: Unknown (Reported after the fact)
- Incident Date: April 2022
- Affected Organization: Gemotest (Russian pharmaceutical company)
- Sector: Healthcare/Pharmaceutical
- Geography: Russia
## Timeline of Events
### Initial Access
- Date/Time: April 2022 (Approximate)
- Vector: Not specified in source material.
- Details: Unauthorized external access leading to data compromise.
### Lateral Movement
- Date/Time: Following initial access.
- Vector: Not specified in source material.
- Details: Not specified in source material.
### Data Exfiltration/Impact
- Date/Time: Following access and data staging.
- Vector: Data Theft/Exfiltration.
- Details: Over 31 million patient records were exposed, including 6.3 million unique email addresses, names, physical addresses, dates of birth, passport numbers, and insurance numbers.
### Detection & Response
- Date/Time: After data was publicized/discovered by monitoring services (e.g., HIBP listing).
- Vector: Not specified, likely external discovery or internal audit flagged by regulatory action.
- Details: Gemotest was later fined for the breach (by July 2022). The breach data was classified as "sensitive" by Have I Been Pwned (HIBP).
## Attack Methodology
- Initial Access: Unknown.
- Persistence: Unknown.
- Privilege Escalation: Unknown.
- Defense Evasion: Unknown.
- Credential Access: Unknown.
- Discovery: Unknown.
- Lateral Movement: Unknown.
- Collection: Collection of large volumes of patient identifiable information (PII).
- Exfiltration: Data was successfully removed from the environment.
- Impact: Mass exposure of patient records, regulatory fine.
## Impact Assessment
- Financial: Gemotest was fined for the data leak (amount specified as RUR 60,000 in allied reporting).
- Data Breach: Exposure of 31 million patient records, including 6.3 million unique emails, names, physical addresses, DOBs, **passport numbers**, and **health insurance information**.
- Operational: Not specified, but data security failure occurred.
- Reputational: High impact due to the sensitive nature of the exposed patient health and government ID data, resulting in regulatory action.
## Indicators of Compromise
- *(No specific IOCs such as IPs, domains, or filenames were provided in the source material.)*
- Behavioral Indicators: Unauthorized access to and bulk extraction of patient database records.
## Response Actions
- Containment: Unknown.
- Eradication: Unknown.
- Recovery actions: Unknown, but the organization faced regulatory consequences and was required to address the security posture leading to the fine.
## Lessons Learned
- Regulatory fines and operational consequences follow significant data protection failures.
- Protection of highly sensitive PII, such as passport and insurance details, demands extremely robust security controls.
- A breach impacting 31 million records indicates potential systemic failures either in perimeter defense or internal data access controls.
## Recommendations
- Immediately review and segregate access to high-value data stores (e.g., containing passport or insurance numbers).
- Implement aggressive monitoring and alerting for large-scale data extraction events.
- Ensure all sensitive data at rest is encrypted, especially data containing government IDs or health information.